• Non ci sono risultati.

Scarica il programma in formato PDF

N/A
N/A
Protected

Academic year: 2022

Condividi "Scarica il programma in formato PDF"

Copied!
2
0
0

Testo completo

(1)

November 29-30, 2018 Reggio Emilia Italy

Auditorium Italy, Ospedale IRCCS - Arcispedale S. Maria Nuova 3

rd

INTERNATIONAL CONGRESS

Clinical Needs and Translational Research in Oncology

Faculty Carlo Aschele La Spezia, I

Massimo Barberis Milan, I Giordano Beretta Bergamo, I Francesco Boccardo Genoa, I

Alba Brandes Bologna, I

Giacomo Cartenì Naples, I

Paolo Casali Milan, I

Alessia Ciarrocchi Reggio Emilia, I Gennaro Ciliberto Rome, I PierFranco Conte Padua, I Giuseppe Curigliano Milan, I Filippo De Braud Milan, I Francesco De Lorenzo Rome, I Ruggero De Maria Rome, I

Marzia Del Re Pisa, I

Federica Di Nicolantonio Turin, I

Mauro Ferrari Houston, US

Antonio Frassoldati Ferrara, I Alessandro Ghirardini Rome, I Felice Giuliante Rome, I

Roberto Grilli Reggio Emilia, I Francesco Grossi Milan, I Massimo Guidoboni Meldola, I Cinzia Iotti Reggio Emilia, I Nancy E. Kemeny New York, US Jonathan A. Ledermann London, UK Yohann Loriot Villejeuf, F

Michele Maio Siena, I

Renzo Mazzarotto Verona, I Nicola Normanno Naples, I Rodolfo Passalacqua Cremona, I Claudio Pedrazzoli Reggio Emilia, I

Sandro Pignata Naples, I

Carmine Pinto Reggio Emilia, I Jordi Remon Masip Barcelona, E

Luigi Ripamonti Rome, I

Marcello Tiseo Parma, I

Gams van Dongen Amsterdam, NL Annibale Versari Reggio Emilia, I

UNRESTRICTED GRANT BY

Carmine Pinto

Medical Oncology Clinical Cancer Centre IRCCS - Arcispedale S. Maria Nuova - REGGIO EMILIA 8,4 ECM / CME have been requested for the following professional

figures: Oncologist, Radiotherapist, Radiologist, Surgeon, Thoracic Surgeon, Urologist, Gastroenterologist, Gynecologist, Pneumologist, Pathologist, Geneticist and Biologist

REGISTRATION is free of charge and has to be done online from the website www.mitcongressi.it section:

3rd INTERNATIONAL CONGRESS

CLINICAL NEEDS AND TRANSLATIONAL RESEARCH IN ONCOLOGY MEETING VENUE

AUDITORIUM ITALY, PAD. CORE

V.le Risorgimento 80 - 42123 Reggio Emilia ITALY

BY CAR

Take the Reggio Emilia exit on the A1 Motorway: follow signs for the hospital (“Ospedale”) and use the parking place entrance located in Via Benedetto Croce.

BY TRAIN

If you use Reggio Emilia railway station “H” minibus route Bus n.1: the stop for bus line 1 for the hospital (“ospedale”) is in front of the station. Get off at the hospital stop on Viale Risorgimento, directly in front of Santa Maria Nuova Hospital.

If you use railway Station Mediopadana AV Bus line 5M

PROVIDER AND LOGISTIC SECRETARIAT

MI&T Srl Viale Carducci, 50 - 40125 Bologna ITALY Tel. 051 220427 - 335 5918811

[email protected] - www.mitcongressi.it

President

GOLD PLATINUM

SILVER

UNDER THE AUSPICES OF

(2)

Cycline inhibitors in hormone-positive breast cancer PierFranco Conte, Padua, I

News in hormonal therapy in prostate cancer Yohann Loriot, Villejeuf, F

Combinations and sequences in renal cancer Giacomo Cartenì, Naples, I

Immunotherapy how long?

Michele Maio, Siena, I Discussion

5:00 pm Coffee break 5:20 pm

Chair: Annibale Versari, Reggio Emilia, I Lecture

Immuno-PET in oncology

Gams van Dongen, Amsterdam, NL NOVEMBER 29, 2018

9:30 am Registration Welcome coffee 10:30 am Introduction

Carmine Pinto, Reggio Emilia, I 10:40 am

Welcome

Authorities Fausto Nicolini General Director

Azienda-USL-IRCCS Reggio Emilia, I Massimo Costantini

Scientific Director

Azienda-USL-IRCCS Reggio Emilia, I 11:00 am

CORE Oncology Award 2018 Lecture

Progress in ovary cancer therapy Sandro Pignata, Naples, I

Lecture

Nanotechnology and cancer Mauro Ferrari, Houston, US

11:45 am 1st NEEDS

IMPACT OF TUMOR MUTATIONAL BURDEN (TMB) IN CANCER THERAPY

Chairs: Alessia Ciarrocchi, Reggio Emilia, I Filippo De Braud, Milan, I

TMB assessment: how, when, why?

Nicola Normanno, Naples, I TMB impact in precision medicine Ruggero De Maria, Rome, I

The clinical trial challenges Giuseppe Curigliano, Milan, I Discussion

1:30 pm Lunch 2:30 pm 2nd NEEDS

MORE ACTIVE DRUG/REGIMEN OR SEQUENCE:

THE CHOICE BETWEEN BIOLOGY AND CLINIC Chairs: Francesco Boccardo, Genoa, I

Massimo Guidoboni, Meldola, I

The biologic and pharmacological background Marzia Del Re, Pisa, I

The evidences in molecular-driven NSCLC Francesco Grossi, Milan, I

3 rd INTERNATIONAL CONGRESS

Clinical Needs and T ranslational R es ea rc h i n O nc olo gy

NOVEMBER 30, 2018 9:00 am

3rd NEEDS

BIOLOGICAL AND CLINICAL IMPACT OF TUMOR HETEROGENEITY AND STROMA

Chairs: Gennaro Ciliberto, Rome, I Antonio Frassoldati, Ferrara, I Technologies and platforms in PD-L1 and

molecular tumor evaluation from tissue to liquid biopsy:

oncologist and pathologist opinions Massimo Barberis, Milan, I

Marcello Tiseo, Parma, I

Progression after TKi and immunotherapy in NSCLC Jordi Remon Masip, Barcelona, E

Primay tumors and metastasis in mCRC Federica Di Nicolantonio, Turin, I

The BRCAm populations

Jonathan A. Ledermann, London, UK Discussion

11:10 am Coffee break 11:30 am

4th NEEDS

LOCAL TREATMENTS IN CANCER THERAPY Chairs: Cinzia Iotti, Reggio Emilia, I

Claudio Pedrazzoli, Reggio Emilia, I Carlo Aschele, La Spezia, I Palliative liver surgery in mCRC Felice Giuliante, Rome, I

Hepatic arterial infusion chemotherapy in liver metastasis Nancy E. Kemeny, New York, US

Stereotactic radiotherapy Renzo Mazzarotto, Verona, I

Intravescical therapy in superficial urothelial cancer Rodolfo Passalacqua, Cremona, I

Discussion 13:00 pm Lecture

Changing paradigms in brain tumor treatment Alba Brandes, Bologna, I

1:30 pm Lunch 2:30 pm 5th NEEDS

EQUITY IN CANCER CARE ACCESS Chairs: Giordano Beretta, AIOM, I

Francesco De Lorenzo, ECPC, I Luigi Ripamonti, Corriere Salute, I Disparity or not in cancer care in Italy?

Alessandro Ghirardini, Agenas, I The European health policy Paolo Casali, ESMO

Appropriate use of healthcare interventions in oncology Roberto Grilli, Reggio Emilia, I

4:00 pm Conclusion

Carmine Pinto, Reggio Emilia, I

Riferimenti

Documenti correlati

CiNZia iOTTi REGGIO EMILIA giOvaNNi laNZa FERRARA. fRaNK

Carmine Pinto (Reggio Emilia), Giancarlo Bisagni (Reggio Emilia) 15.00 LA MALATTIA NELLA DONNA CON RO POSITIVI. QUESITO: QUALI EVIDENZE PER GLI INIBITORI DELLE CICLINE,

17.00 - 17.45 Commissione Lungosopravviventi-comorbidità Moderatori: Attilio Guarini (Bari), Stefano Luminari (Reggio Emilia). 17.00 Presentazione attività commissione

Vanesa Gregorc, Oncologia Medica, Milano Filippo Lococo, Chirurgia Toracica, Reggio Emilia Maria Antonietta Mazzei, Radiodiagnostica, Siena Massimiliano Paci, Chirurgia Toracica,

Carlo Aschele - La Spezia Editta Baldini - Lucca Giulia Barletta - Genova Marco Benasso - Savona Roberta Buosi - Casale Simona Coco - Genova Diego Cortinovis - Monza Carlotta

Reggio Emilia , Arcispedale Santa Maria Nuova, Padiglione Rocca

CARLO ASCHELE LA SPEZIA ALbERTO bALLESTRERO GENOVA bRUNELLA bARbARO ROMA CARLO bARONE ROMA GIORDANO bERETTA ROMA STEFANO bERTI LA SPEZIA GIAN ANDREA bINDA GENOVA FRANCESCO

Casali, Reggio Emilia 9.45 Making sense of big data in health research:.. towards an EU